Clinical Trials Sponsored by Steven Baker

Total 3831 results

Bayer

Completed

Loose-dose Combination of Acarbose and Metformin for T2DM in Metformin-failure Patients

Diabetes Mellitus, Type 2

China
Bayer

Completed

Thorough ECG (Electrocardiogram) and Drug Interaction Study With Anetumab Ravtansine and Itraconazole

Medical Oncology

United States, Belgium, Spain, France, Netherlands, Australia
Bayer

Completed

Evaluation of a Treat and Extend Regimen of Intravitreal Aflibercept for Macular Edema Secondary to CRVO (CENTERA)

Central Retinal Vein Occlusion

France, Canada, Denmark, Germany, Italy, Spain, United Kingdom, Australia
Bayer

Completed

Study to Investigate Safety, Absorption, Elimination, and Drug Effect of BAY2327949 in Participants With Different Renal Function Status

Pharmacokinetics

Germany
Bayer

Completed

Study on the Safety of BAY 63-2521, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given as a Single Oral Dose of 1 mg Tablet in Participants With Impaired Liver Function and Healthy Participants Matched for Age-, Gender-, and Weight

Clinical Pharmacology

Germany
Bayer

Completed

A Study to Gain Information How Well Dexpanthenol Derma Cream Helps the Face Skin to Recover After Cosmetic Lasering

Erythema | Skin Recovery

Brazil
Bayer

Completed

Drug-drug Interaction Between Rifampicin and Progestins/Ethinylestradiol and Midazolam

Biological Availability

Germany
Bayer

Completed

A Study to Gain Information How Well Dexpanthenol Dermal Spray Helps the Skin to Recover After Laser Hair Removal in the Groin and Intimate Area

Skin Recovery

Brazil
Bayer

Terminated

Study Testing Radium-223 Dichloride in Relapsed Multiple Myeloma

Multiple Myeloma

Korea, Republic of, Spain, United States
Bayer

Withdrawn

Assessment of Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 7)

Uterine Fibroids

Japan
Bayer

Completed

A Study to Evaluate Changes in Nasal Airflow of Loratadine/Pseudoephedrine Tablet and Fluticasone Propionate Nasal Spray in Subjects Following Allergen Exposure

Rhinitis, Allergic

Canada
Bayer

Approved for marketing

Expanded Access to Provide Larotrectinib for the Treatment of Cancers With a NTRK Gene Fusion

Tumors Harboring NTRK Fusion
Bayer

Completed

Study to Develop a Tool to Estimate the Kidney Function in Databases Without Laboratory Data

Renal Function

United States
Bayer

Completed

Phase Ib Study of Anetumab Ravtansine in Combination With Pegylated Liposomal Doxorubicin in Patients With Recurrent Mesothelin-expressing Platinum-resistant Cancer

Ovarian Neoplasms

Belgium, Spain, Moldova, Republic of, United States
Bayer

Completed

A Study to Assess Menstrual Cramp Pain Associated With Primary Dysmenorrhea

Dysmenorrhea

United States
Bayer

Terminated

Sivextro in Acute Bacterial Skin and Skin Structure Infection (ABSSSI) in Hospitalized Patients. A Global Observational Study (DART)

Skin Disease, Infectious

Russian Federation, Mexico, Singapore
Bayer

Completed

To Evaluate Effectiveness of Visanne in Improving Quality of Life in Asian Women With Endometriosis (ENVISIOeN)

Endometriosis

Korea, Republic of, Indonesia, Malaysia, Philippines, Singapore, Thailand
Bayer

Completed

Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934 (DIALOGUE4)

Renal Insufficiency, Chronic | Anemia

United States, Japan
Bayer

Completed

Study to Assess the Safety of BAY1067197 in Stable Heart Failure Patients on Standard Therapy Including ß-blocker

Heart Failure

Netherlands
Bayer

Completed

BAY94-9027 PK Study Comparing to Another Long Acting Product

Hemophilia A

Bulgaria
Bayer

Completed

Clinical Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Pharmacodynamic Effects of a Single and Multiple Oral BAY1101042 Tablet Doses in Healthy Male Subjects

Healthy Volunteer

Germany
Bayer

Completed

A Study in Healthy Volunteers Investigating How Quickly and to What Extent BAY1817080 is Taken up, Distributed, Broken Down and Eliminated From the Body, as Well as the Difference Between 2 Different Types of Tablets of BAY1817080 and the Difference Between Oral Dose and Dose in the Vein

Biological Availability

Netherlands
Bayer

Completed

An Evaluation of a Customized Insole to Provide Relief From Heel Pain Due to Plantar Fasciitis or General Heel Pain When Used in Footwear Over a Period of Four Weeks

Foot Orthoses

United States
Bayer

Completed

Food Effect, Oral & Intravenous Pharmacokinetics and Absolute Bioavailability of BAY1834845 Including Drug-drug Interaction With Methotrexate

Inflammation

Netherlands
Bayer

Completed

Standard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the Bone

Prostatic Neoplasms

United States, Canada, Taiwan, Spain, Australia, Czechia, Germany, Israel, Korea, Republic of, France, Brazil, Chile, Italy, Sweden, United Kingdom
Bayer

Completed

Multiple Dose Study in Heart Failure of BAY 1067197 (PARSiFAL)

Heart Failure

Germany, Netherlands, Italy, Poland
Bayer

Terminated

To Investigate the Pharmacological Effects, Drug Blood Levels and Safety of an Intrauterine System Releasing the Study Drug BAY1007626 in Comparison to Mirena and Jaydess in Healthy Young Women Treated for 90 Days to Determine the Drug Dose for Further Development

Contraception

Germany, Netherlands, United Kingdom
Bayer

Completed

Nexavar-Tarceva Combination Therapy for First Line Treatment of Patients Diagnosed With Hepatocellular Carcinoma (SEARCH)

Carcinoma, Hepatocellular

Belgium, France, Spain, Hong Kong, United States, Canada, Germany, Greece, New Zealand, Russian Federation, Australia, Taiwan, Austria, United Kingdom, China, Israel, Korea, Republic of, Bulgaria, Brazil, Poland, Italy, Colombia, South... and more
Bayer

Completed

BAY1436032 in Patients With Mutant IDH1(mIDH1) Advanced Acute Myeloid Leukemia (AML)

Leukemia, Myeloid, Acute

United States, Germany
Bayer

Completed

Inhaled Iloprost in the Treatment of Patients With Pulmonary Hypertension up to 4 Years (OPTION)

Pulmonary Hypertension

Turkey
Bayer

Completed

A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Reduced Ejection Fraction (PANTHEON)

Heart Failure

United States, Israel, Spain, Poland, Japan, Italy, Belgium, Bulgaria, Germany, Greece, Netherlands
Bayer

Completed

Qlaira rPMS (Regulatory Post Marketing Surveillance) Study in Korea

Contraception

Korea, Republic of
Bayer

Completed

First in Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and to Explore Pharmacodynamics of BAY1834845

Pelvic Inflammatory Disease

Germany
Bayer

Completed

Non-interventional Study on Compliance of Inhaled Treatment With Ventavis in Patient With Pulmonary Hypertension (IVENT)

Hypertension, Pulmonary

Russian Federation
Bayer

Completed

A Pharmacokinetic Trial of Naproxen Sodium and Diphenhydramine Hydrochloride Soft Capsules Versus Naproxen Sodium and Diphenhydramine Hydrochloride Tablets in Healthy Adult Subjects Under Fed Conditions

Clinical Pharmacology

United States
Bayer

Completed

Evaluate Analgesic Efficacy of Fast Release Aspirin (TAROT)

Drugs, Investigational

United States
Bayer

Terminated

Efficacy of a Single Dose of Aspirin vs. Acetaminophen in Tension Type Headache (Tarot Headache)

Headache

United States
Bayer

Completed

18750-Sun Protection Factor Assay (SPF Assay)

Sunscreening Agents

United States
Bayer

Completed

18794 - Human Photo Toxicity Test

Sunscreening Agents

United States
Bayer

Completed

Sun Protection Factor Assay (SPF Assay)

Sunscreening Agent

United States
Bayer

Completed

Sun Protection Factor Assay (SPF Assay 202/2016)

Sunscreening Agents

United States
Bayer

Completed

Sun Protection Factor Assay (SPF Assay 18677) (SPF Assay)

Sunscreening Agent

United States
Bayer

Completed

18793 - Human Photoallergy Test

Sunscreening Agents

United States
Bayer

Completed

Evaluation of Sunscreen During Exercise Under Conditions of Profuse Sweating

Sunscreening Agent

United States
Bayer

Completed

Sun Protection Factor Assay (SPF Assay 205/2016)

Sunscreening Agents

United States
Bayer

Completed

Sun Protection Factor Assay (SPF Assay 206/2016)

Sunscreening Agents

United States
Bayer

Completed

Sun Protection Factor Assay (SPF Assay 200/2016)

Sunscreening Agents

United States
Bayer

Completed

Human Phototoxicity Test

Sunscreening Agents

United States
Bayer

Completed

Human Photoallergy Test (824/2016)

Sunscreening Agents

United States
Bayer

Completed

Outdoor-Use Test for Sunscreen Products in Children Ages 3 to 9 Years Old

Sunscreening Agent

United States

3

Subscribe